159 related articles for article (PubMed ID: 24282087)
21. Liver X receptor α inhibits osteosarcoma cell proliferation through up-regulation of FoxO1.
Chang YW; Zhao YF; Cao YL; Gu XF; Li ZQ; Wang SQ; Miao JH; Zhan HS
Cell Physiol Biochem; 2013; 32(1):180-6. PubMed ID: 23867395
[TBL] [Abstract][Full Text] [Related]
22. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
23. Twist1 promotes gastric cancer cell proliferation through up-regulation of FoxM1.
Qian J; Luo Y; Gu X; Zhan W; Wang X
PLoS One; 2013; 8(10):e77625. PubMed ID: 24204899
[TBL] [Abstract][Full Text] [Related]
24. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
25. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
26. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
Zhang Z; Zhang W; Mao J; Xu Z; Fan M
Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
[TBL] [Abstract][Full Text] [Related]
27. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive bioinformatics analysis reveals the oncogenic role of FoxM1 and its impact on prognosis, immune microenvironment, and drug sensitivity in osteosarcoma.
Shi S; Wang Q; Du X
J Appl Genet; 2023 Dec; 64(4):779-796. PubMed ID: 37782449
[TBL] [Abstract][Full Text] [Related]
30. SPOCD1 promotes cell proliferation and inhibits cell apoptosis in human osteosarcoma.
Liang J; Zhao H; Hu J; Liu Y; Li Z
Mol Med Rep; 2018 Feb; 17(2):3218-3225. PubMed ID: 29257309
[TBL] [Abstract][Full Text] [Related]
31. MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.
Tian X; Zhang J; Yan L; Dong JM; Guo Q
Int J Clin Exp Pathol; 2015; 8(6):6442-9. PubMed ID: 26261520
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-139 inhibits the proliferation and migration of osteosarcoma cells via targeting forkhead-box P2.
Zhong C; Liu J; Zhang Y; Luo J; Zheng J
Life Sci; 2017 Dec; 191():68-73. PubMed ID: 28993144
[TBL] [Abstract][Full Text] [Related]
33. Cadmium chloride enhances cisplatin sensitivity in osteosarcoma cells by reducing FOXM1 expression.
Hu K; Xie W; Ni S; Yan S; Tian G; Qi W; Duan Y
Oncol Rep; 2020 Aug; 44(2):650-660. PubMed ID: 32627005
[TBL] [Abstract][Full Text] [Related]
34. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
35. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
Cao J; Han X; Qi X; Jin X; Li X
Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
[TBL] [Abstract][Full Text] [Related]
36. FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas.
Kim KM; Hussein UK; Park SH; Kang MA; Moon YJ; Zhang Z; Song Y; Park HS; Bae JS; Park BH; Ha SH; Moon WS; Kim JR; Jang KY
J Exp Clin Cancer Res; 2019 Jun; 38(1):267. PubMed ID: 31215499
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer.
Kong X; Li L; Li Z; Le X; Huang C; Jia Z; Cui J; Huang S; Wang L; Xie K
Cancer Res; 2013 Jul; 73(13):3987-96. PubMed ID: 23598278
[TBL] [Abstract][Full Text] [Related]
39. FOXM1-LDHA signaling promoted gastric cancer glycolytic phenotype and progression.
Jiang W; Zhou F; Li N; Li Q; Wang L
Int J Clin Exp Pathol; 2015; 8(6):6756-63. PubMed ID: 26261559
[TBL] [Abstract][Full Text] [Related]
40. WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway.
Wang X; Zhao X; Yi Z; Ma B; Wang H; Pu Y; Wang J; Wang S
Cell Biol Int; 2018 May; 42(5):598-607. PubMed ID: 29345412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]